All Stories

  1. Quantifying the coverage of the human proteome with renewable antibodies

    Article • June 2023, Cold Spring Harbor Laboratory Press

    Harvinder Virk, Anita E Bandrowski

  2. Tales of Unexpected Career Turns

    Article • eLife, April 2023, eLife

    Harvinder Virk

  3. P134 Once daily fibrinolytic therapy in the management of pleural infection

    Article • November 2022, BMJ

    Harvinder Virk

  4. Lack of Benefit of High Flow Nasal Oxygen Therapy as Ceiling of Treatment for Severe COVID-19 Pneumonitis in Elderly Frail Patients: A Single Centre Observational Study

    Article • The Open Respiratory Medicine Journal, October 2022, Bentham Science Publishers

    Harvinder Virk

  5. TGFβ1 induces resistance of human lung myofibroblasts to cell death via down‐regulation of TRPA1 channels

    Article • British Journal of Pharmacology, May 2021, Wiley

    Harvinder Virk

  6. Validation of antibodies for the specific detection of human TRPA1

    Article • Scientific Reports, December 2019, Springer Science + Business Media

    Harvinder Virk

  7. TRPA1 ion channel expression in human lung myofibroblasts

    Article • September 2019, European Respiratory Society (ERS)

    Harvinder Virk

  8. Validation of a sensitive, specific and quantitative flow cytometry assay for the measurement of TRPA1 protein expression in primary human lung cells and leukocytes

    Article • September 2019, European Respiratory Society (ERS)

    Harvinder Virk

  9. TGFß1-induces resistance to apoptosis in human lung myofibroblasts via TRPA1 downregulation

    Article • September 2019, European Respiratory Society (ERS)

    Harvinder Virk

  10. Mast cells and their activation in lung disease

    Article • Translational Research, August 2016, Elsevier

    Harvinder Virk